Science
Mechanism of Action
Operating at a cellular level, this extract exhibits anti-senescence effects by upregulating the anti-apoptotic protein BCL2 while concurrently downregulating apoptotic markers such as p21, CASP3, BAX, and BAD. Its key component, ferulic acid, is a powerful antioxidant, shielding dermal fibroblasts from oxidative stress and UV-induced damage by inhibiting caspase activation. Further contributing to its multi-faceted action are alpha-pinene, offering anti-inflammatory benefits, and azulene, known for its skin-soothing properties. The extract can also modulate phase II detoxification enzymes and genes involved in inflammation, apoptosis, and antioxidant defense pathways, with sulfur compounds imparting antimicrobial activity.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In vitro studies on human dermal fibroblasts (HDFs) demonstrated revitalizing effects at concentrations between 5 × 10⁻⁸ to 10⁻⁷ g/mL. Within this range, it significantly reduced β-galactosidase activity, a marker of senescence, and enhanced the proliferation of normal fibroblasts.
- 02 Additionally, in vitro analysis confirmed potent, concentration-dependent antioxidant activity and xanthine oxidase inhibition.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The gum fraction is water-soluble, allowing for easy dispersion. Optimal extraction pH is between 6.5-7.0 at 85-90°C. While emulsions containing 20% w/v of the gum extract showed stable viscosity and droplet size over storage, thermal analysis indicates weight loss below and above 100°C, suggesting temperature sensitivity for the extract itself.
Conflicts
- High concentrations of disulfide-containing compounds, which are implicated in skin irritation and pro-inflammatory responses.
- Its characteristic strong, pungent, garlic-like odor, attributed to sulfurous volatile oils, necessitates careful consideration for cosmetic formulations, particularly for fragrance-sensitive products.
Safety
Safety Profile
While FDA GRAS for food flavoring (21 CFR 182.206), a dedicated safety assessment for topical cosmetic use by CIR or SCCS is currently unavailable. Critical attention to concentration is required, as levels exceeding 5 × 10⁻⁷ g/mL were found to be cytotoxic to human dermal fibroblasts, inducing cell death and activating pro-inflammatory signals. There are reports of contact dermatitis in infants following topical application, potentially linked to its disulfide compounds. Furthermore, oral intake is restricted during pregnancy, and large oral dosages may lead to systemic side effects.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite promising anti-senescence and antioxidant effects at extremely low concentrations, the ingredient presents significant formulation and safety challenges including a narrow therapeutic window, potential for sensitization, and a strong intrinsic odor.
Related
Similar Ingredients
Finding similar ingredients…